228 related articles for article (PubMed ID: 29512066)
1. CSF N-Glycomics Using MALDI MS Techniques in Alzheimer's Disease.
Palmigiano A; Messina A; Bua RO; Barone R; Sturiale L; Zappia M; Garozzo D
Methods Mol Biol; 2018; 1750():75-91. PubMed ID: 29512066
[TBL] [Abstract][Full Text] [Related]
2. CSF N-Glycomics Using MALDI MS Techniques.
Messina A; Romeo DA; Barone R; Sturiale L; Palmigiano A; Zappia M; Garozzo D
Methods Mol Biol; 2024; 2785():49-65. PubMed ID: 38427187
[TBL] [Abstract][Full Text] [Related]
3. CSF N-Glycoproteomics Using MALDI MS Techniques in Neurodegenerative Diseases.
Messina A; Palmigiano A; Bua RO; Romeo DA; Barone R; Sturiale L; Zappia M; Garozzo D
Methods Mol Biol; 2019; 2044():255-272. PubMed ID: 31432418
[TBL] [Abstract][Full Text] [Related]
4. Analysis of N- and O-linked glycans from glycoproteins using MALDI-TOF mass spectrometry.
Morelle W; Faid V; Chirat F; Michalski JC
Methods Mol Biol; 2009; 534():5-21. PubMed ID: 19277556
[TBL] [Abstract][Full Text] [Related]
5. CSF N-glycoproteomics for early diagnosis in Alzheimer's disease.
Palmigiano A; Barone R; Sturiale L; Sanfilippo C; Bua RO; Romeo DA; Messina A; Capuana ML; Maci T; Le Pira F; Zappia M; Garozzo D
J Proteomics; 2016 Jan; 131():29-37. PubMed ID: 26455811
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Invertebrate and Protist N-Glycans.
Hykollari A; Paschinger K; Eckmair B; Wilson IB
Methods Mol Biol; 2017; 1503():167-184. PubMed ID: 27743366
[TBL] [Abstract][Full Text] [Related]
7. N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.
Everest-Dass AV; Briggs MT; Kaur G; Oehler MK; Hoffmann P; Packer NH
Mol Cell Proteomics; 2016 Sep; 15(9):3003-16. PubMed ID: 27412689
[TBL] [Abstract][Full Text] [Related]
8. Sensitive and robust MALDI-TOF-MS glycomics analysis enabled by Girard's reagent T on-target derivatization (GTOD) of reducing glycans.
Zhang Y; Wang B; Jin W; Wen Y; Nan L; Yang M; Liu R; Zhu Y; Wang C; Huang L; Song X; Wang Z
Anal Chim Acta; 2019 Feb; 1048():105-114. PubMed ID: 30598139
[TBL] [Abstract][Full Text] [Related]
9. High-Throughput and High-Sensitivity Mass Spectrometry-Based N-Glycomics of Mammalian Cells.
Holst S; van Pelt GW; Mesker WE; Tollenaar RA; Belo AI; van Die I; Rombouts Y; Wuhrer M
Methods Mol Biol; 2017; 1503():185-196. PubMed ID: 27743367
[TBL] [Abstract][Full Text] [Related]
10. Tear N-glycomics in vernal and atopic keratoconjunctivitis.
Messina A; Palmigiano A; Tosto C; Romeo DA; Sturiale L; Garozzo D; Leonardi A
Allergy; 2021 Aug; 76(8):2500-2509. PubMed ID: 33583051
[TBL] [Abstract][Full Text] [Related]
11. Profiling N-glycans of the egg jelly coat of the sea urchin Paracentrotus lividus by MALDI-TOF mass spectrometry and capillary liquid chromatography electrospray ionization-ion trap tandem mass spectrometry systems.
Şahar U; Deveci R
Mol Reprod Dev; 2017 May; 84(5):401-407. PubMed ID: 28295836
[TBL] [Abstract][Full Text] [Related]
12. Glycoblotting method allows for rapid and efficient glycome profiling of human Alzheimer's disease brain, serum and cerebrospinal fluid towards potential biomarker discovery.
Gizaw ST; Ohashi T; Tanaka M; Hinou H; Nishimura S
Biochim Biophys Acta; 2016 Aug; 1860(8):1716-27. PubMed ID: 26968461
[TBL] [Abstract][Full Text] [Related]
13. A carbon nanoparticles-based solid-phase purification method facilitating sensitive MALDI-MS analysis of permethylated N-glycans.
Zhong J; Banazadeh A; Peng W; Mechref Y
Electrophoresis; 2018 Dec; 39(24):3087-3095. PubMed ID: 30086189
[TBL] [Abstract][Full Text] [Related]
14. Comparative glycomic profiling in esophageal adenocarcinoma.
Hammoud ZT; Mechref Y; Hussein A; Bekesova S; Zhang M; Kesler KA; Novotny MV
J Thorac Cardiovasc Surg; 2010 May; 139(5):1216-23. PubMed ID: 20412957
[TBL] [Abstract][Full Text] [Related]
15. CSF N-Glycomics Using High-Throughput UPLC-ESI Techniques in Alzheimer's Disease.
Messina A; Barone R; Sturiale L; Zappia M; Palmigiano A; Garozzo D
Methods Mol Biol; 2024; 2785():37-48. PubMed ID: 38427186
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a combined glycomics and glycoproteomics approach for studying the major glycoproteins present in biofluids: Application to cerebrospinal fluid.
Goyallon A; Cholet S; Chapelle M; Junot C; Fenaille F
Rapid Commun Mass Spectrom; 2015 Mar; 29(6):461-73. PubMed ID: 26160412
[TBL] [Abstract][Full Text] [Related]
17. Comparing MALDI-MS, RP-LC-MALDI-MS and RP-LC-ESI-MS glycomic profiles of permethylated N-glycans derived from model glycoproteins and human blood serum.
Hu Y; Mechref Y
Electrophoresis; 2012 Jul; 33(12):1768-77. PubMed ID: 22740465
[TBL] [Abstract][Full Text] [Related]
18. Stable isotopic labeling-based quantitative targeted glycomics (i-QTaG).
Kim KJ; Kim YW; Kim YG; Park HM; Jin JM; Hwan Kim Y; Yang YH; Kyu Lee J; Chung J; Lee SG; Saghatelian A
Biotechnol Prog; 2015; 31(3):840-8. PubMed ID: 25832445
[TBL] [Abstract][Full Text] [Related]
19. A MALDI-MS-based quantitative targeted glycomics (MALDI-QTaG) for total N-glycan analysis.
Kim KJ; Kim YW; Hwang CH; Park HG; Yang YH; Koo M; Kim YG
Biotechnol Lett; 2015 Oct; 37(10):2019-25. PubMed ID: 26063621
[TBL] [Abstract][Full Text] [Related]
20. High-throughput profiling of protein N-glycosylation by MALDI-TOF-MS employing linkage-specific sialic acid esterification.
Reiding KR; Blank D; Kuijper DM; Deelder AM; Wuhrer M
Anal Chem; 2014 Jun; 86(12):5784-93. PubMed ID: 24831253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
